ALOX5 and inflammatory bowel disease: PPARγ is a potential regulator of arachidonic acid metabolism; agonists for PPARγ effectively down regulate COX-2 and 5-LOX, which is found useful in the treatment of inflammation associated disorders, for instance, inflammatory bowel disease [24].